Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2014

01-08-2014 | Clinical Practice: Clinical Vignettes

Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones

Authors: Vikas Khullar, MD, Ankur Jain, MD, Maryam Sattari, MD, MS

Published in: Journal of General Internal Medicine | Issue 8/2014

Login to get access

ABSTRACT

Designer drugs represent an increasingly popular form of recreational substance abuse, especially amongst young adults. The two classes of designer drugs that have recently risen to prominence are the synthetic cannabinoids and synthetic cathinones. These substances are not detected by conventional drug screening methods and can often be associated with serious health consequences, including seizures, renal failure and death. Thus, clinicians should be familiar with the signs, symptoms, and toxicities associated with the use of these substances, and maintain a high level of suspicion for synthetic drugs as an alternative means of “getting high.” We present a case of a 20-year-old college student who presented to the emergency department with altered mental status and severe agitation who later admitted to using bath salts. The goal of this article is to raise awareness about these new designer drugs, their clinical presentation, and management of their intoxication.
Literature
2.
go back to reference Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):849–63.PubMedCrossRef Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(5):849–63.PubMedCrossRef
3.
go back to reference Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49(10):910–41.PubMedCrossRef Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49(10):910–41.PubMedCrossRef
7.
go back to reference Gershman JA, Fass AD. Synthetic cathinones ('bath salts'): legal and health care challenges. P T. 2012;37(10):571–95.PubMedCentralPubMed Gershman JA, Fass AD. Synthetic cathinones ('bath salts'): legal and health care challenges. P T. 2012;37(10):571–95.PubMedCentralPubMed
10.
12.
go back to reference Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother. 2012;46(3):436–41.PubMedCrossRef Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother. 2012;46(3):436–41.PubMedCrossRef
13.
14.
go back to reference Mugele J, Nanagas KA, Tormoehlen LM. Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med. 2012;60(1):100–2.PubMedCrossRef Mugele J, Nanagas KA, Tormoehlen LM. Serotonin syndrome associated with MDPV use: a case report. Ann Emerg Med. 2012;60(1):100–2.PubMedCrossRef
15.
go back to reference Caffery T, Musso M, Manausa R, Everett J, Perret J. Riding high on cloud 9. J La State Med Soc. 2012;164(4):186–9.PubMed Caffery T, Musso M, Manausa R, Everett J, Perret J. Riding high on cloud 9. J La State Med Soc. 2012;164(4):186–9.PubMed
17.
go back to reference Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 2010;160(3):585–93.PubMedCentralPubMedCrossRef Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 2010;160(3):585–93.PubMedCentralPubMedCrossRef
18.
go back to reference Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.PubMedCrossRef Auwarter V, Dresen S, Weinmann W, Muller M, Putz M, Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 2009;44(5):832–7.PubMedCrossRef
19.
go back to reference Jiang W, Zhang Y, Xiao L, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005;115(11):3104–16.PubMedCentralPubMedCrossRef Jiang W, Zhang Y, Xiao L, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest. 2005;115(11):3104–16.PubMedCentralPubMedCrossRef
20.
go back to reference Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int. 2009;106(27):464–7.PubMedCentralPubMed Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of "spice gold". Dtsch Arztebl Int. 2009;106(27):464–7.PubMedCentralPubMed
21.
22.
go back to reference Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & Experimental Toxicology. 2012;31(10):1006–11.CrossRef Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & Experimental Toxicology. 2012;31(10):1006–11.CrossRef
23.
go back to reference Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.PubMedCentralPubMed Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012;17(2):177–81.PubMedCentralPubMed
25.
go back to reference Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157–62.PubMedCrossRef Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157–62.PubMedCrossRef
26.
go back to reference Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7. Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128(6):e1622–7.
27.
go back to reference Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26(6):462–5.PubMedCrossRef Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26(6):462–5.PubMedCrossRef
28.
go back to reference Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. Netherlands. 2010;118:309–10.CrossRef Muller H, Sperling W, Kohrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. Netherlands. 2010;118:309–10.CrossRef
29.
go back to reference Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use. Clin Schizophr Relat Psychoses. Mar 21 2013: 1–13. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use. Clin Schizophr Relat Psychoses. Mar 21 2013: 1–13.
30.
go back to reference Acute kidney injury associated with synthetic cannabinoid use–multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):93–8. Acute kidney injury associated with synthetic cannabinoid use–multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):93–8.
31.
go back to reference Kazory A, Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association. Clinical Kidney Journal. 2013;6(3):330–3.CrossRef Kazory A, Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association. Clinical Kidney Journal. 2013;6(3):330–3.CrossRef
32.
go back to reference Daccarett M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol. Netherlands. 2007;119:235–6.CrossRef Daccarett M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol. Netherlands. 2007;119:235–6.CrossRef
33.
go back to reference Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.PubMedCrossRef Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.PubMedCrossRef
34.
go back to reference Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication–a case report of possible association. Med Sci Monit. 2000;6(2):386–9.PubMed Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication–a case report of possible association. Med Sci Monit. 2000;6(2):386–9.PubMed
35.
go back to reference Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997;36(1):45–8.PubMedCrossRef Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997;36(1):45–8.PubMedCrossRef
36.
go back to reference Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how 'safe' is it? Eur Neurol. 2000;44(1):42–4. Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how 'safe' is it? Eur Neurol. 2000;44(1):42–4.
37.
go back to reference Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60(4):435–8.PubMedCrossRef Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60(4):435–8.PubMedCrossRef
38.
39.
go back to reference Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694–701.PubMedCrossRef Yucel M, Solowij N, Respondek C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694–701.PubMedCrossRef
40.
go back to reference Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010;200(1–3):141–7.PubMedCrossRef Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010;200(1–3):141–7.PubMedCrossRef
41.
go back to reference Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med. 2012;79(4):258–64.PubMedCrossRef Jerry J, Collins G, Streem D. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon. Cleve Clin J Med. 2012;79(4):258–64.PubMedCrossRef
Metadata
Title
Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones
Authors
Vikas Khullar, MD
Ankur Jain, MD
Maryam Sattari, MD, MS
Publication date
01-08-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2802-4

Other articles of this Issue 8/2014

Journal of General Internal Medicine 8/2014 Go to the issue

Clinical Practice: Clinical Images

An Unusual Cause of ST Elevations in a Young Man